User menu

Mode of action of calcium antagonists: voltage-dependence and kinetics of drug-receptor interaction.

Bibliographic reference Wibo, Maurice. Mode of action of calcium antagonists: voltage-dependence and kinetics of drug-receptor interaction.. In: Pharmacology & toxicology, Vol. 65, no. 1, p. 1-8 (1989)
Permanent URL http://hdl.handle.net/2078.1/24802
  1. Bean, Proc. Natl. Acad. Sci. USA, 81, 6388 (1984)
  2. Bean B. P., Sturek M., Puga A., Hermsmeyer K., Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs, 10.1161/01.res.59.2.229
  3. Bechem, Trends Pharmacol. Sci., 9, 257 (1988)
  4. Benham, Nature, 328, 275 (1987)
  5. Bolger, J. Pharmacol. Exp. Therap., 225, 291 (1983)
  6. Bolton, Physiol. Rev., 59, 606 (1979)
  7. Byrne N G, Large W A, Membrane ionic mechanisms activated by noradrenaline in cells isolated from the rabbit portal vein., 10.1113/jphysiol.1988.sp017306
  8. Cauvin, Ann. Rev. Pharmacol. Toxicol., 23, 373 (1983)
  9. Cohen C J, McCarthy R T, Nimodipine block of calcium channels in rat anterior pituitary cells., 10.1113/jphysiol.1987.sp016570
  10. Cohen, Proc. Natl. Acad. Sci. USA, 85, 2412 (1988)
  11. Dacquet, Biochem. Biophys. Res. Commun., 152, 1165 (1988)
  12. Droogmans, Pflügers Arch., 409, 7 (1987)
  13. Fleckenstein, Calcium antagonism in heart and smooth muscle. Experimental facts and therapeutic prospects. (1983)
  14. Gabella, An introduction to the structural variety of smooth muscles, 13 (1983)
  15. Galizzi, Proc. Natl. Acad. Sci. USA, 83, 7513 (1986)
  16. Godfraind T, Calcium exchange in vascular smooth muscle, action of noradrenaline and lanthanum., 10.1113/jphysiol.1976.sp011501
  17. Godfraind, J. Pharmacol. Exp. Therap., 224, 443 (1983)
  18. Godfraind, J. Pharmacol. Exp. Therap., 217, 510 (1981)
  19. Godfraind, Pharmacology & Toxicology, 61, 79 (1987)
  20. Godfraind, Effects of dihydropyridines on human and animal isolated vessels, 309 (1985)
  21. GODFRAIND T., KABA A., Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle, 10.1111/j.1476-5381.1969.tb08010.x
  22. Godfraind, Circ. Res., 52, 81 (1983)
  23. GODFRAIND T., MILLER R.C., LIMA J. SOCRATES, SELECTIVE α1-AND α2-ADRENOCEPTOR AGONIST-INDUCED CONTRACTIONS AND 45Ca FLUXES IN THE RAT ISOLATED AORTA, 10.1111/j.1476-5381.1982.tb09337.x
  24. Godfraind, Pharmacol. Rev., 38, 321 (1986)
  25. Godfraind T., Wibo M., Subcellular localization of [3H]-nitrendipine binding sites in guinea-pig ileal smooth muscle, 10.1111/j.1476-5381.1985.tb08866.x
  26. Gurney, J. Gen. Physiol., 86, 353 (1985)
  27. Hamilton, Mol. Pharmacol., 31, 221 (1987)
  28. Hansen, Acta physiol. scand., 113, 437 (1981)
  29. Hering, Pflügers Arch, 411, 590 (1988)
  30. Hof, J. Cardiovasc. Pharmacol., 6, 399 (1984)
  31. Janis, Adv. Drug Res., 16, 309 (1987)
  32. Jones, Smooth muscle: an assessment of current knowledge., 397 (1981)
  33. Kanaya, J. Mol. Cell. Cardiol., 15, 145 (1983)
  34. Klöckner, Eur. J. Pharmacol., 127, 165 (1986)
  35. Kokubun, Mol. Pharmacol., 30, 571 (1986)
  36. Lee, Nature, 302, 790 (1983)
  37. McDonald T F, Pelzer D, Trautwein W, Cat ventricular muscle treated with D600: characteristics of calcium channel block and unblock., 10.1113/jphysiol.1984.sp015288
  38. Morel, J. Pharmacol. Exp. Therap., 243, 711 (1987)
  39. Morel Nicole, Godfraind Théophile, Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery, 10.1111/j.1476-5381.1988.tb16571.x
  40. Qar, Mol. Pharmacol., 33, 363 (1988)
  41. Reynolds, Proc. Natl. Acad. Sci. USA, 83, 8804 (1986)
  42. Sanguinetti M. C., Kass R. S., Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists, 10.1161/01.res.55.3.336
  43. Siesjö, Ann. N.Y. Acad. Sci., 522, 638 (1988)
  44. Taylor, Trends Pharmacol. Sci., 9, 272 (1988)
  45. Tokuno, Eur. J. Pharmacol., 141, 131 (1987)
  46. Towart, Arzneimittelforsch., 32, 338 (1982)
  47. Triggle, Modern methods in pharmacology., 1 (1984)
  48. Tytgat J., Vereecke J., Carmeliet E., Differential effects of verapamil and flunarizine on cardiac L-type and T-type Ca channels, 10.1007/bf00175798
  49. Uehara, J. Gen. Physiol., 85, 621 (1985)
  50. Breemen, Pharmacol. Rev., 30, 167 (1979)
  51. Nueten, Arch. Int. Pharmacodyn. Ther., 204, 37 (1973)
  52. Nueten, Arch. Int. Pharmacodyn. Ther., 232, 42 (1978)
  53. Wibo M., DeRoth L., Godfraind T., Pharmacologic relevance of dihydropyridine binding sites in membranes from rat aorta: kinetic and equilibrium studies, 10.1161/01.res.62.1.91
  54. Wibo, Arch. Int. Pharmacodyn. Ther., 270, 333 (1984)
  55. Wibo, Biochim. Biophys. Acta, 649, 651 (1981)
  56. Worley, Proc. Natl. Acad. Sci. USA, 83, 5746 (1986)
  57. Yatani A., Seidel C. L., Allen J., Brown A. M., Whole-cell and single-channel calcium currents of isolated smooth muscle cells from saphenous vein, 10.1161/01.res.60.4.523